Literature DB >> 26240263

Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP Inhibition as a Strategy to Reduce Cardiovascular Risk: The Pro Case.

Philip J Barter1, Stephen J Nicholls2, John J P Kastelein2, Kerry-Anne Rye2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26240263     DOI： 10.1161/CIRCULATIONAHA.114.014025

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  11 in total

1.  The lipid transfer properties of CETP define the concentration and composition of plasma lipoproteins.

Authors:  Richard E Morton; Yan Liu
Journal:  J Lipid Res       Date:  2020-06-26       Impact factor: 5.922

2.  Reduction in PCSK9 levels induced by anacetrapib: an off-target effect?

Authors:  Philip J Barter; Fatiha Tabet; Kerry-Anne Rye
Journal:  J Lipid Res       Date:  2015-09-16       Impact factor: 5.922

3.  Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism.

Authors:  Yan Liu; Richard E Morton
Journal:  Curr Opin Lipidol       Date:  2020-08       Impact factor: 4.776

4.  Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits.

Authors:  Jifeng Zhang; Manabu Niimi; Dongshan Yang; Jingyan Liang; Jie Xu; Tokuhide Kimura; Anna V Mathew; Yanhong Guo; Yanbo Fan; Tianqing Zhu; Jun Song; Rose Ackermann; Yui Koike; Anna Schwendeman; Liangxue Lai; Subramaniam Pennathur; Minerva Garcia-Barrio; Jianglin Fan; Y Eugene Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-04-20       Impact factor: 8.311

5.  Effect of evacetrapib on cardiovascular outcomes in patients with high-risk cardiovascular disease.

Authors:  Wilbert S Aronow
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

6.  Identification of a hormone response element that mediates suppression of APOF by LXR and PPARα agonists.

Authors:  Yan Liu; Lahoucine Izem; Richard E Morton
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-12-06       Impact factor: 4.698

Review 7.  Trials and Tribulations of CETP Inhibitors.

Authors:  Alan R Tall; Daniel J Rader
Journal:  Circ Res       Date:  2017-10-10       Impact factor: 17.367

8.  Apolipoprotein F concentration, activity, and the properties of LDL controlling ApoF activation in hyperlipidemic plasma.

Authors:  Richard E Morton; Daniel Mihna
Journal:  J Lipid Res       Date:  2022-01-08       Impact factor: 5.922

9.  Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E.

Authors:  John S Millar; Michael E Lassman; Tiffany Thomas; Rajasekhar Ramakrishnan; Patricia Jumes; Richard L Dunbar; Emil M deGoma; Amanda L Baer; Wahida Karmally; Daniel S Donovan; Hashmi Rafeek; John A Wagner; Stephen Holleran; Joseph Obunike; Yang Liu; Soumia Aoujil; Taylor Standiford; David E Gutstein; Henry N Ginsberg; Daniel J Rader; Gissette Reyes-Soffer
Journal:  J Lipid Res       Date:  2017-03-17       Impact factor: 5.922

10.  Extra Virgin Olive Oil Prevents the Age-Related Shifts of the Distribution of HDL Subclasses and Improves Their Functionality.

Authors:  Alyann Otrante; Amal Trigui; Roua Walha; Hicham Berrougui; Tamas Fulop; Abdelouahed Khalil
Journal:  Nutrients       Date:  2021-06-29       Impact factor: 5.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.